World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
51276
World Ranking
4062
National Ranking
2225

Emil J. Freireich publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Emil J. Freireich sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 559 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Emil J. Freireich D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Emil J. Freireich sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 118 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1996 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Emil J. Freireich was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research career was associated with this institution, contributing to the academic and clinical environment there.

The scientist's recognized professional memberships included being a Fellow of the American Association for the Advancement of Science (AAAS), awarded in 1996. Additionally, they were a member of the Association of American Physicians.

There are no recorded recent papers, frequent co-authors, publication venues, book publications, or specific fields and subfields of study available in the data.

Best Publications

  • Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

    Gerald P. Bodey;Monica Buckley;Y. S. Sathe;Emil J Freireich

  • Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

    Freireich Ej;Gehan Ea;Rall Dp;Schmidt Lh

  • Flow Cytometry in Clinical Cancer Research

    Barthel Barlogie;Martin N. Raber;Johannes Schumann;Tod S. Johnson

  • Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.

    Sewa S. Legha;Robert S. Benjamin;Bruce Mackay;Michael Ewer

  • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

    Alvaro Aguayo;Hagop M Kantarjian;Taghi Manshouri;Cristi Gidel

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

    Hagop Kantarjian;Deborah Thomas;Susan O'Brien;Jorge Cortes

  • Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

    Susan M. O’Brien;Hagop Kantarjian;Deborah A. Thomas;Francis J. Giles

  • Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

    M. J. Keating;Hagop M Kantarjian;M. Talpaz;J. Redman

  • Causes of Death in Acute Leukemia: A Ten-Year Study of 414 Patients From 1954-1963.

    Evan M. Hersh;Gerald P. Bodey;Boyd A. Nies;Emil J Freireich

  • Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.

    M. J. Keating;S. O'Brien;S. Lerner;C. Koller

  • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

    Hagop Kantarjian;Susan O'Brien;Farhad Ravandi;Jorge Cortes

  • Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

    Philip A. Thompson;Constantine S. Tam;Susan M. O'Brien;William G. Wierda

  • Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

    Ming Sheng Lee;Kun Sang Chang;Fernando Cabanillas;Emil J. Freireich

  • Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.

    Hagop M. Kantarjian;Farhad Ravandi;Susan OBrien;Jorge Cortes

  • Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.

    Hagop M Kantarjian;Varsha Gandhi;Jorge Cortes;Srdan Verstovsek

  • Cellular DNA content as a marker of neoplasia in man.

    Barthel Barlogie;Benjamin Drewinko;Johannes Schumann;Wolfgang Göhde

  • Causes of death in adults with acute leukemia.

    Hui Yen Chang;Victorio Rodriguez;Gino Narboni;Gerald P. Bodey

  • Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients

    Hagop M. Kantarjian;Michael J. Keating;Moshe Talpaz;Ronald S. Walters

  • The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia

    E. Frei;M. Karon;R. H. Levin;E. J. Freireich

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Elihu H. Estey
Elihu H. Estey University of Washington
Jorge E. Cortes
Jorge E. Cortes Augusta University
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center
Francis J. Giles
Francis J. Giles Northwestern University
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Jordan U. Gutterman
Jordan U. Gutterman The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor. There are various online degree programs and alternative pathways that can lead to a rewarding future in healthcare. Many students consider the easiest rn program options to jumpstart their nursing careers, providing a more accessible entry into healthcare roles.

For registered nurses looking to expand their qualifications, there are cheap rn to bsn online programs available. These accredited programs allow nurses to earn their Bachelor of Science in Nursing at a lower cost and with greater flexibility, making advancement more achievable.

Even individuals with non-nursing backgrounds can transition into the field through options like the non nursing bachelor's to msn online pathway. These direct-entry Master of Science in Nursing programs are designed for those who hold degrees in other fields but want to become advanced practice nurses.

For those seeking terminal degrees, the online nursing doctorate offers opportunities to move into research, teaching, or high-level leadership positions in healthcare. These advanced degrees can typically be earned online, adding both convenience and affordability.

Best Scientists Citing Emil J. Freireich